[
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE): Among Jeff Smith’s Top Activist Targets",
    "summary": "We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, having […]",
    "url": "https://finnhub.io/api/news?id=0410de8ac30d98ffa45dbffb65f0d834599038680c21795f30b71da4e75a915f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745078273,
      "headline": "Pfizer Inc. (PFE): Among Jeff Smith’s Top Activist Targets",
      "id": 134022911,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "We recently published a list of Jeff Smith’s Top 10 Activist Targets and Their Returns Compared to the S&P 500. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other Jeff Smith’s top activist targets. Jeff Smith is arguably the “most feared man” in corporate America, having […]",
      "url": "https://finnhub.io/api/news?id=0410de8ac30d98ffa45dbffb65f0d834599038680c21795f30b71da4e75a915f"
    }
  },
  {
    "ts": null,
    "headline": "3 Magnificent Stocks to Buy That Are Near 52-Week Lows",
    "summary": "It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration.  Zoetis (NYSE: ZTS) is a global leader in animal health, with an extensive portfolio of medicines, vaccines, and diagnostic products for livestock and pets.  The company's diversification, covering 17 products generating over $100 million in annual revenue, including several best-in-class treatments, underscores its appeal as an investment.",
    "url": "https://finnhub.io/api/news?id=1e4e9d0c44a3b9b308482597b3051652778f7689f6e3eeb8fb6a5d1f45d77fe5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745065800,
      "headline": "3 Magnificent Stocks to Buy That Are Near 52-Week Lows",
      "id": 134022912,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "It's been a tough start to 2025 for investors amid concerns regarding the strength of the U.S. economy and uncertainties over the effect of sweeping changes in trade policy under the Trump administration.  Zoetis (NYSE: ZTS) is a global leader in animal health, with an extensive portfolio of medicines, vaccines, and diagnostic products for livestock and pets.  The company's diversification, covering 17 products generating over $100 million in annual revenue, including several best-in-class treatments, underscores its appeal as an investment.",
      "url": "https://finnhub.io/api/news?id=1e4e9d0c44a3b9b308482597b3051652778f7689f6e3eeb8fb6a5d1f45d77fe5"
    }
  }
]